Izervay injections for geographic atrophy led to acute IOP increases in 3% of eyes in a real-world dataset published in ...
A new campaign for Astellas Pharma’s Izervay is aimed at opening retina specialists’ eyes to the unique role they play in their geographic atrophy (GA) patients’ lives. | A new campaign for Astellas ...
COLUMBUS – Prevent Blindness Ohio is declaring February as Age-related Macular Degeneration and Low Vision Month in an effort to provide education and various expert-approved resources to the public ...
“In GA, light is not transduced into electrical signals because of a loss of photoreceptors, which leads to an absolute scotoma (blind spot). 2,3 The PRIMA neurostimulation system replaces the lost ...
New research highlights progress in treating age-related macular degeneration, including late‑stage drug trials, gene therapy strategies, and a wireless retinal prosthesis that restored limited ...
Age-related macular degeneration, known as AMD, is one of the leading causes of vision loss in Australia, quietly affecting ...
All patients dosed with SPVN06 in Phase I/II trial continue to demonstrate a favorable safety profileInitial data readout for this novel ...
WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its fourth quarter ...
Delve into the Astellas playbook, a strategy relying on "strategic brand" and advancing on "primary focuses" at the same time ...
NervGen Pharma Corp. ("NervGen" or the "Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class ...
The biotechnology firm Ocugen is approaching a critical transformation, shifting from a pure research and development entity to a commercial-stage company in th ...
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced the appointment of Rita Johnson-Greene as chief financial officer. The company said Johnson-Greene brings more than 20 years of experience in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results